MedPath

Clinical study for the effectiveness of Unani drug in Ezema

Phase 2
Conditions
Health Condition 1: L209- Atopic dermatitis, unspecified
Registration Number
CTRI/2020/03/024360
Lead Sponsor
uqman Unani Medical College hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Patients full-filling Hanifin and Rajkaâ??s criteria

2 Patients with mild to moderate eczema

3 Patients of both gender,

4 Patients in age group of 18 to 65years

Exclusion Criteria

1 Patients who are allergic to any product as well as history or presence any type of malignancy including any skin cancer or suspicious lesions.

2 Any systemic illness

3 Pregnant and lactating mothers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath